Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pulmonary Arterial Hypertension, Children
Conditions
Pulmonary Arterial Hypertension, Children
Trial Timeline
Aug 1, 2003 → Jun 1, 2008
NCT ID
NCT00159913About Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate
Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate is a phase 3 stage product being developed by Pfizer for Pulmonary Arterial Hypertension, Children. The current trial status is completed. This product is registered under clinical trial identifier NCT00159913. Target conditions include Pulmonary Arterial Hypertension, Children.
What happened to similar drugs?
20 of 20 similar drugs in Pulmonary Arterial Hypertension, Children were approved
Approved (20) Terminated (1) Active (0)
✅Arformoterol Tartrate Inhalation Solution + Arformoterol Tartrate Inhalation Solution + PlaceboSumitomo PharmaApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00159913 | Phase 3 | Completed |
Competing Products
20 competing products in Pulmonary Arterial Hypertension, Children